Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study.

Front Immunol · 2023 · PMC10200982 · PMID 37223097

Europe PMC DOI

hedged sentence

0.2000

closest p · 4.0× alpha

0.2000

boldest claim

The sentences

did not reach statistical significancep = 0.20not close (p > 0.1)

In addition, although the difference did not reach statistical significance, most of the patients with disease exacerbation in the ERP belonged to the thymoma-related MG group ( p = 0.20).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.